Antiviral therapy in cytomegalovirus-positive ulcerative colitis: A systematic review and meta-analysis
Authors:
Open Access
- 1 January 2014
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 20 (10) , 2695-703
Abstract
To evaluate the impact of antiviral treatment on cytomegalovirus (CMV)-positive ulcerative colitis patients. We performed a systematic review and meta-analysis (MA) of comparative cohort and case-control studies published between January 1966 and March 2013. Studies focusing on colectomy series and studies including only less than 3 patients in the treated or non-treated arm were excluded. The primary outcome was colectomy within 30 d of diagnosis. Secondary outcomes included colectomy during the follow-up period Subgroup analyses by method of detection of CMV, study design, risk of bias and country of origin were performed. Quality of studies was evaluated according to modified New-Castle Ottawa Scale. After full-text review, nine studies with a total of 176 patients were included in our MA. All the included studies were of low to moderate quality. Patients who have received antiviral treatment had a higher risk of 30-d colectomy (OR = 2.40; 95%CI: 1.05-5.50; I² = 37.2%). A subgroup analysis including only patients in whom CMV diagnosis was based did not demonstrate a significant difference between the groups (OR = 3.41; 95%CI: 0.39-29.83; I² = 56.9%). Analysis of long-term colectomy rates was possible for 6 studies including 110 patients. No statistically significant difference was found between the treated and untreated groups (OR = 1.71; 95%CI: 0.71-4.13; 6 studies, I² = 0%). Analysis of mortality rate was not possible due to a very limited number of cases. Stratification of the outcomes by disease severity was not possible. No positive association between antiviral treatment and a favorable outcome was demonstrated. These findings should be interpreted cautiously due to primary studies' quality and potential biases.Keywords
This publication has 28 references indexed in Scilit:
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipientsCochrane Database of Systematic Reviews, 2013
- Cytomegalovirus positive ulcerative colitis: A single center experience and literature reviewWorld Journal of Gastrointestinal Pathophysiology, 2013
- The Prevalence and Efficacy of Ganciclovir on Steroid-refractory Ulcerative Colitis With Cytomegalovirus InfectionJournal of Clinical Gastroenterology, 2012
- Natural history of cytomegalovirus infection in a series of patients diagnosed with moderate-severe ulcerative colitisWorld Journal of Gastroenterology, 2011
- Acute Cytomegalovirus Infection Is a Risk Factor in Refractory and Complicated Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 2008
- Clinical evaluation of patients with inflammatory connective tissue diseases complicated by cytomegalovirus antigenemiaModern Rheumatology, 2006
- Clinical and Immunologic Aspects of Cytomegalovirus Infection in Solid Organ Transplant RecipientsTransplantation, 2005
- Cytomegalovirus Infection in Steroid-refractory Ulcerative ColitisAmerican Journal of Surgical Pathology, 2004
- Cytomegalovirus as an Exacerbating Factor in Ulcerative ColitisJournal of Clinical Gastroenterology, 1994
- Cytomegalic inclusion disease and ulcerative colitisThe American Journal of Medicine, 1961